Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Lupus Institute
Colleague Insights
Conferences
Resource Library
Sign in
Join now
story of the week
Published in COVID-19 and
1 other channel

Journal Scan / Research · May 20, 2021

NSAIDS and Susceptibility to COVID-19

Arthritis & Rheumatology (Hoboken, N.J.)

 

 Save  Recommend
 Share

Additional Info

Arthritis & Rheumatology (Hoboken, N.J.)
Nonsteroidal Antiinflammatory Drugs and Susceptibility to COVID-19
Arthritis Rheumatol 2021 May 01;73(5)731-739, JS Chandan, DT Zemedikun, R Thayakaran, N Byne, S Dhalla, D Acosta-Mena, KM Gokhale, T Thomas, C Sainsbury, A Subramanian, J Cooper, A Anand, KO Okoth, J Wang, NJ Adderley, T Taverner, AK Denniston, J Lord, GN Thomas, CD Buckley, K Raza, N Bhala, K Nirantharakumar, S Haroon

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated